ArticleBMC public health2026
Timing is everything: optimizing maternal RSV immunization through ANC attendance patterns and timing in Viet Nam.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMaternal immunization against respiratory syncytial virus (RSV) offers a promising strategy to reduce severe respiratory infections and hospitalizations among infants, particularly in low- and middle-income countries such as Viet Nam. Administered during antenatal care (ANC), success of maternal RSV immunization programs depends on alignment of ANC visits with vaccine timing recommendations.
methodsWe conducted a retrospective cross-sectional study at 15 health facilities across levels of care in Viet Nam. Records from ANC registers for women attending at least one visit in 2023 were included. We analyzed gestational age at ANC visits, visit frequency, and attendance within two vaccine eligibility windows: the window used in Viet Nam (24-36 weeks' gestation) and the World Health Organization (WHO)-recommended window (≥ 28 weeks' gestation).
resultsAmong 7,349 women, ANC attendance and visit frequency varied by level of care. Women attending primary facilities had recorded ANC visits earlier (13 weeks' gestation) and attended more frequently (median four visits) than those at secondary (38 weeks', median one visit) and tertiary facilities (32 weeks', median one visit). Attendance within RSV vaccine eligibility windows also differed by level of care. At primary facilities, 47% of women had at least one recorded visit during Viet Nam's eligibility window, increasing to 88% under the WHO-recommended window. At secondary facilities, 26% had a recorded visit during Viet Nam's window compared to 85% under the WHO window, while at tertiary facilities, corresponding proportions were 36% and 69%, respectively. Daily vaccine-eligible ANC attendance varied by level of care, with higher-level facilities receiving more eligible women.
conclusionsThis study demonstrates the importance of aligning maternal RSV immunization strategies with ANC attendance patterns across levels of care in Viet Nam. Primary facilities, characterized by earlier and more frequent ANC engagement, are critical platforms for maternal vaccination. Adopting the wider WHO-recommended eligibility window, strengthening early ANC counseling, expanding public-sector access, and improving digital continuity of care are essential to achieving equitable national rollout.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.